Clinical Trial Update: Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform [Phase 2]

View source ↗

Summary

This update describes a Phase 2 clinical trial evaluating a disulfiram/copper combination for newly diagnosed glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Copper (copper)
• Disulfiram (Disulfiram)

Snippet

Sponsor: Olympion Medical Center | Conditions: Glioblastoma Multiforme | Phase 2 | Status: NOT_YET_RECRUITING